Total Payments
$7,747
2024 Payments
$163.74
Companies
50
Transactions
360
Medicare Patients
941
Medicare Billing
$76,664
Payment Breakdown by Category
Food & Beverage$7,682 (99.2%)
Other$64.71 (0.8%)
Education$0.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,682 | 357 | 99.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64.71 | 2 | 0.8% |
| Education | $0.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $666.81 | 18 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $580.94 | 16 | $0 (2022) |
| Biogen, Inc. | $572.24 | 25 | $0 (2024) |
| Amgen Inc. | $551.01 | 15 | $0 (2019) |
| UCB, Inc. | $526.83 | 31 | $0 (2019) |
| GENZYME CORPORATION | $444.34 | 23 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $359.93 | 25 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $352.97 | 17 | $0 (2019) |
| Allergan Inc. | $310.40 | 13 | $0 (2019) |
| Genentech USA, Inc. | $282.97 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.74 | 6 | E.R. Squibb & Sons, L.L.C. ($74.65) |
| 2023 | $643.88 | 21 | Biogen, Inc. ($259.08) |
| 2022 | $224.38 | 13 | Celgene Corporation ($81.21) |
| 2020 | $37.19 | 2 | Grifols USA, LLC ($21.08) |
| 2019 | $2,519 | 105 | Teva Pharmaceuticals USA, Inc. ($513.87) |
| 2018 | $2,681 | 147 | Sunovion Pharmaceuticals Inc. ($336.65) |
| 2017 | $1,478 | 66 | Arbor Pharmaceuticals, Inc. ($226.44) |
All Payment Transactions
360 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/14/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: NEUROLOGY | ||||||
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $74.65 | General |
| Category: Neuroscience | ||||||
| 01/19/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: IMMUNOLOGY | ||||||
| 01/17/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Neurology | ||||||
| 01/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Neurology | ||||||
| 11/16/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Immunology | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Neurology | ||||||
| 10/25/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: Neuroscience | ||||||
| 10/05/2023 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/04/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| Category: Neurology | ||||||
| 10/03/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: UPLIZNA | ||||||
| 08/29/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $95.00 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/22/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Neurology | ||||||
| 08/21/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neurology | ||||||
| 07/12/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: UPLIZNA | ||||||
| 05/31/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Neurology | ||||||
| 05/30/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $93.12 | General |
| Category: Neurology | ||||||
| 04/19/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neurology | ||||||
| 03/08/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Neurology | ||||||
| 03/07/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $119.02 | General |
| Category: Neurology | ||||||
| 03/07/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: UPLIZNA | ||||||
| 02/15/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: Neuroscience | ||||||
| 02/14/2023 | Genentech USA, Inc. | Enspryng (Biological), Ocrevus | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Immunology | ||||||
| 01/30/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 361 | 398 | $86,393 | $22,404 |
| 2022 | 8 | 298 | 339 | $96,774 | $28,089 |
| 2021 | 1 | 37 | 37 | $10,581 | $3,873 |
| 2020 | 9 | 245 | 287 | $62,123 | $22,298 |
Total Patients
941
Total Services
1,061
Medicare Billing
$76,664
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 63 | 85 | $15,640 | $5,689 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 57 | 66 | $8,184 | $2,985 | 36.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 43 | 43 | $7,998 | $2,459 | 30.7% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 29 | 29 | $12,296 | $2,172 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 22 | 22 | $6,270 | $1,990 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 18 | $4,464 | $1,648 | 36.9% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 29 | 29 | $14,100 | $1,195 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $4,784 | $1,137 | 23.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 29 | 29 | $3,248 | $963.20 | 29.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,705 | $812.62 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,728 | $779.23 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,976 | $574.47 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 72 | $17,856 | $8,049 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 46 | 55 | $13,640 | $5,358 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $7,980 | $2,592 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 38 | $6,992 | $2,555 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $5,415 | $2,030 | 37.5% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 17 | 17 | $7,208 | $1,429 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 18 | $3,312 | $1,318 | 39.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,325 | $1,186 | 22.3% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2022 | 23 | 24 | $20,520 | $1,049 | 5.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $3,906 | $1,019 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 14 | 14 | $2,604 | $857.32 | 32.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 17 | 18 | $2,016 | $646.64 | 32.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $7,410 | $2,768 | 37.3% |
About Dr. Christopher Sinclair, M.D
Dr. Christopher Sinclair, M.D is a Neurology healthcare provider based in Port Jefferson, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205987351.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Sinclair, M.D has received a total of $7,747 in payments from pharmaceutical and medical device companies, with $163.74 received in 2024. These payments were reported across 360 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,682).
As a Medicare-enrolled provider, Sinclair has provided services to 941 Medicare beneficiaries, totaling 1,061 services with total Medicare billing of $76,664. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Vascular Neurology
- Location Port Jefferson, NY
- Active Since 01/16/2007
- Last Updated 07/21/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205987351
Products in Payments
- APTIOM (Drug) $666.81
- Aimovig (Biological) $536.63
- AJOVY (Drug) $526.87
- Briviact (Drug) $486.70
- TYSABRI (Biological) $444.85
- Horizant (Drug) $352.97
- LEMTRADA (Drug) $280.74
- OCREVUS (Biological) $263.96
- NUPLAZID (Drug) $233.58
- TROKENDI XR (Drug) $228.06
- Gamunex-C (Biological) $219.18
- INGREZZA (Drug) $208.45
- Duopa (Drug) $190.53
- ZEPOSIA (Drug) $188.09
- ACTHAR (Biological) $186.05
- BOTOX (Biological) $166.44
- AUBAGIO (Drug) $163.60
- RYTARY (Drug) $147.70
- SOLIRIS (Drug) $146.05
- OXTELLAR XR (Drug) $131.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.